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ABSTRACT
Cyclodipeptide synthases (CDPSs) use two
aminoacyl-tRNA substrates in a sequential ping-
pong mechanism to form a cyclodipeptide. The
crystal structures of three CDPSs have been de-
termined and all show a Rossmann-fold domain
similar to the catalytic domain of class-I aminoacyl-
tRNA synthetases (aaRSs). Structural features
and mutational analyses however suggest that
CDPSs and aaRSs interact differently with their
tRNA substrates. We used AlbC from Streptomyces
noursei that mainly produces cyclo(l-Phe-l-Leu)
to investigate the interaction of a CDPS with its
substrates. We demonstrate that Phe-tRNAPhe is the
first substrate accommodated by AlbC. Its binding
to AlbC is dependent on basic residues located in
the helix 4 that form a basic patch at the surface of
the protein. AlbC does not use all of the Leu-tRNALeu
isoacceptors as a second substrate. We show that
the G1-C72 pair of the acceptor stem is essential for
the recognition of the second substrate. Substitution
of D163 located in the loop 6–7 or D205 located in
the loop 6–8 affected Leu-tRNALeu isoacceptors
specificity, suggesting the involvement of these
residues in the binding of the second substrate. This
is the first demonstration that the two substrates of
CDPSs are accommodated in different binding sites.
INTRODUCTION
Cyclodipeptide synthases (CDPSs) form a family of tRNA-
dependent enzymes that catalyse the synthesis of various
cyclodipeptides, which are the precursors of various sec-
ondary metabolites with important biological activities (1–
3). CDPSs use two aminoacyl-tRNA (aa-tRNA) substrates
in a sequential ping-pong mechanism to form the two pep-
tide bonds of cyclodipeptides (4–7). The first catalytic steps
involve the binding of the first aa-tRNA to the CDPSs and
the subsequent transfer of the aminoacyl moiety onto an
active-site serine residue to form an acyl-enzyme intermedi-
ate. The acyl-enzyme then reacts with the aminoacyl moiety
of the second aa-tRNA substrate to form a dipeptidyl inter-
mediate that undergoes intramolecular cyclisation, yielding
the final cyclodipeptide product.
Crystal structures are available for three CDPSs (4–6).
The three CDPSs share an architecture that is very simi-
lar to the catalytic domain of class-I aminoacyl-tRNA syn-
thetases (aaRSs), especially class-Ic TyrRSs and TrpRSs.
Conventional aaRSs catalyse the formation of aa-tRNAs
in a two-step reaction consisting of activation of the amino
acid by formation of an aminoacyl-adenylate intermedi-
ate, followed by esterification at the 3’-hydroxyl of a cog-
nate tRNA. CDPSs would have diverged from conventional
aaRSs and acquired new active site residues, converting
them into cyclodipeptide-forming enzymes, for which aa-
tRNAs are the substrates instead of the final products (8).
This evolutionary event would have entailed significant di-
vergence between CDPSs and class-Ic aaRSs (4–6). First,
class-Ic aaRSs are homodimers that have interdigitation of
the two active sites at the dimer interface whereas CDPSs
are active as monomers. Second, the specific signature mo-
tifs involved in ATP binding are absent in CDPSs, con-
sistent with the absence of ATP-dependent activation by
CDPSs. Third, the tRNA-binding domain involved in in-
teraction with the anti-codon loop of tRNA in aaRSs is
absent in CDPSs. CDPSs possess instead a large patch of
positively charged residues that are absent in aaRSs. Fi-
nally, unlike aaRSs, CDPSs exhibit a large tRNA substrate
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specificity. Although each characterized CDPS preferen-
tially synthesizes one predominant cyclodipeptide, most of
these enzymes are promiscuous and produce several cy-
clodipeptides. For example, AlbC from Streptomyces nour-
sei synthesizes cyclo(L-Phe-L-Leu) (cFL) and Ndas 1148
from Nocardiopsis dassonvillei synthesizes cyclo(L-Phe-L-
Tyr) (cFY), but both enzymes produce appreciable amounts
of other phenylalanyl-containing cyclodipeptides (cyclo(L-
Phe-L-X), in which X indicated any of the incorporated
amino acids) (cFX). Rv2275 from Mycobacterium tubercu-
losis mostly produces cYY but also cYX cyclodipeptides,
and the YvmC enzymes from Bacillus species mainly pro-
duce cLL and cLX compounds (2,9).
No crystal structure has yet been obtained for a CDPS
in complex with a ligand representative of its natural
substrates. Nevertheless, the structural similarity between
CDPSs and aaRSs, and extensive mutagenesis analyses of
CDPSs have provided insight into the interaction of these
enzymes with their aa-tRNA substrates (4–6). CDPSs have
a surface-accessible pocket containing the catalytic residues
that superimposes well with the amino acid-binding pocket
of class-Ic aaRSs. This pocket accommodates the aminoa-
cyl moiety of one of the two aa-tRNA substrates (5). The
cyclodipeptides formed by a given CDPS almost invariably
have one amino acid in common. This suggests that only the
aminoacyl group of the first substrate, probably the ‘com-
mon’ aminoacyl group, binds and remains in the catalytic
pocket, whereas the second substrate is probably accommo-
dated at a different site with less stringent recognition (6).
The involvement of the tRNA moiety of either substrate
in substrate binding and selectivity is poorly documented.
Mutagenesis studies and tRNA-binding assays identified
two regions of CDPSs that are likely to interact with tRNA:
the positively charged patchmentioned above and a loop lo-
cated between helices 6 and 7 (5,6).
Here, we studied the interaction of CDPSs with their
two aa-tRNA substrates. To discriminate the interaction
of either substrate with the enzyme, we worked with AlbC
that uses two different substrates, Phe-tRNAPhe and Leu-
tRNALeu, to catalyse cFL synthesis. We show that Phe-
tRNAPhe is specifically bound in the first step of the reac-
tion. We also show the involvement of the nucleotide se-
quence of the acceptor stem in the recognition of the tRNA
moiety of the second substrate and identify key bases in-
volved in substrate specificity. Finally, we explored the role
of residues predicted to interact with the tRNA moiety of
the substrates and demonstrated that AlbC possesses differ-
ent binding sites for its two aa-tRNA substrates.
MATERIALS AND METHODS
Mutagenesis and purification of AlbC variants
Genes coding the six new single point variants of AlbC
(R80A, R102A, N159A, R160A, D163A, D205A) were ob-
tained via polymerase chain reaction (PCR) mutagenesis of
the plasmid pQE60-AlbC encoding C-terminal His6-tagged
AlbC (5) according to the QuikChangeTM site-directed mu-
tagenesis method (Stratagene). Sequences were verified by
DNA sequencing. Plasmids encoding the other AlbC vari-
ants used in this study (R91A, K94A, R98A, R98A-R99A)
were constructed previously (5).
The C-terminal His6-tagged proteins were produced and
purified as described previously (2,5). Purified proteins were
quantified by UV spectrophotometry. Protein molecular
weights were verified by electrospray ionisation mass spec-
trometry (Esquire HCT ion trapmass spectrometer (Bruker
Daltonik, GmbH)).
In vitro transcription/semi-synthesis
tRNAPhe, tRNALeu isoacceptors and tRNALeuTAA mu-
tants were obtained by in vitro transcription of double-
stranded DNA templates (10). Double-stranded DNA tem-
plates were synthesized by PCR using three synthetic DNA
oligonucleotides purchased from Eurogentec. For site-
directed mutagenesis of the acceptor stem, the first oligonu-
cleotide (Matrix) includes complementary sequence of the
tRNA from positions 8 to 65. To avoid mis-transcription
products, a second oligonucleotide (Forward) containing
the T7 promoter sequence is fused to the tRNA sequence
from positions 1 to 26. Finally, a third oligonucleotide (Re-
verse) includes the complementary sequence of the tRNA
from positions 47 to 76. Sequences of the oligonucleotides
used for synthesis of tRNAPhe and tRNALeu isoacceptors
are given in Supplementary Table S1. Amplified double-
stranded DNA templates are used for in vitro transcription
with T7 RNA polymerase as previously described (11) ex-
cept for A1-U72 tRNALeuTAA where guanosine monophos-
phate (GMP) is replaced by adenosine monophosphate
(AMP). Transcripts of tRNA were separated from the re-
action mixture by extraction with phenol/chloroform and
precipitation with ethanol. The tRNAs were purified by
size exclusion chromatography (Superdex R© 75 HR 10/30,
GE Healthcare). The concentrations of tRNAs were deter-
mined by absorption at 260 nm (1 OD260 unit equivalent to
40 g/ml) and were further corrected by plateau charging
(see below).
Cloning, mutagenesis and purification of Escherichia coli
tRNA
The plasmid encoding tRNAPhe, pBSTNAV2/tRNAPhe,
was a gift from Y. Mechulam (Ecole Polytech-
nique, Palaiseau, France) (12). The plasmid encoding
tRNALeuCAG was constructed as follows: tRNALeuCAG
was amplified from a lysate of E. coli K12 using
Thermo Scientific Phusion High-Fidelity DNA poly-
merase according to the manufacturer’s guidelines.
The primers used included EcoRI and PstI restric-
tion sites (underlined) as follows: CTTGTAACGC
TGAATTCGCGAAGGTGGCGGAATTG (forward) and
CGCTAAGGATCTGCAGTGGTGCGAGGGGGGGG
(reverse). Amplified fragments were digested by FastDigest
EcoRI and PstI (Thermo Scientific) and ligated into the
digested pBSTNAV2 vector using T4 DNA ligase (Thermo
Scientific) according to the manufacturer’s protocol.
The two double mutants C1-G72 tRNALeuCAG
and C1-G72 tRNAPhe were obtained from wild-
type sequences cloned into a pBSTNAV2 vector
by amplification with oligonucleotides containing
the desired mutation (in bold): LeuG1C (GTAACG
CTGAATTCCCGAAGGTGGCGGAATTG), LeuC72G
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(CTAAGGATCTGCAGTGGTCCGAGGGGGG),
PheG1C (CTTGTAACGCTGAATTCCCCCGGATAGC
TCAGTC), PheC72G (CGCTAAGGATCTGCAGTG
GTCCCCGGACTCGGAATC). Amplified fragments
were treated as described above for wild-type sequences.
All constructions were verified by DNA sequencing.
Production and purification of tRNAswere performed as
previously described (13). Briefly, cells overexpressing tR-
NAs were harvested by centrifugation and tRNAs were ex-
tracted by phenol followed by centrifugation steps and pre-
cipitation with ethanol. The pellet was suspended in 20 mM
Tris-HCl pH 7.5, 0.1 mM EDTA, 8 mM MgCl2, 0.2 M
NaCl and tRNAs were purified by Q-Sepharose Fast Flow
column with a linear gradient of 0.4 M to 0.7 M NaCl.
The fractions containing tRNAs were precipitated by iso-
propanol and stored at −20◦C after centrifugation and sus-
pension in water.
Acylation of tRNAs
The concentration of aminoacylated tRNAwas determined
from plateau charging experiments. The assay was per-
formed in buffer A (50 mMHEPES-KOH pH 7.5, 150 mM
KCl, 15 mMMgCl2, 0.1 mMEDTA, 2 mMATP, 10 mMß-
mercaptoethanol) with 1 MPheRS or LeuRS and 50 M
of radiolabelled amino acids (L-[14C]Leu, 324 mCi/mmol
(12.0 GBq mmol−1), or L-[14C]Phe, 487 mCi/mmol (18.0
GBq mmol−1), Perkin-Elmer). The reaction was incubated
for 10min at 30◦Cand aa-tRNAswere precipitated with 5%
TCA and 0.5% casamino acids, filtered onWhatmanGF/C
filters and quantified by liquid scintillation counting. Mu-
tated tRNAswere aminoacylated for different times; 15min
was enough to ensure complete acylation.
AlbC coupled assay
TheCDPS activity of AlbCwas determined in a coupled as-
say containing aaRSs to generate in situ the aa-tRNA sub-
strates as described previously (7). The standard assay was
performed in buffer A, with 50 M Phe and Leu, 50 nM
AlbC or AlbC variant, 1 M PheRS and LeuRS, and aa-
tRNAs at the concentrations specified in the text. The reac-
tion was carried out at 30◦Cwith a preincubation of 15 min
with the aaRSs prior to the addition of AlbC for the synthe-
sis of aa-tRNAs. Under these conditions, the tRNAs were
completely acylated at the beginning of the AlbC reaction
and remained acylated during the entire reaction (Supple-
mentary Figure S1). The enzymatic reaction was initiated
by the addition of AlbC. Aliquots were withdrawn at vari-
ous times, acidified with 2% TFA to stop the reaction and
mixed with known concentrations of stable isotope internal
standards (13C9,15N-labelled cFF and cFL solutions), prior
to cFF and cFL quantification by liquid chromatography
coupled to mass spectrometry (LC-MS) as described previ-
ously (2,7).
Detection of acyl-enzyme intermediates
Purified AlbC wild-type, pSHaeC06 (positive controls),
AlbC S37A (negative control) and AlbC variants were in-
cubated with [14C]Phe-tRNAPhe or [14C]Leu-tRNALeuCAG
(0.5 M). The labelled substrates were obtained as de-
scribed previously (5). The enzyme was added at a final con-
centration of 1 M. After 30 s of incubation, the reaction
was quenched and analysed. Radioactivity was detected on
polyvinylidene difluoride (PVDF) membranes by a Beta-
ImagerTM 2000 (Biospace) (5).
RESULTS
AlbC discriminates Phe-tRNAPhe and Leu-tRNALeu
Post-transcriptional modification of tRNAs is not required
for AlbC activity. We previously showed that AlbC is ac-
tive when it is produced in E. coli. AlbC mainly synthe-
sizes cFL but also produces appreciable amounts of other
L-Phe-containing cyclodipeptides, especially cFF (2). We
also showed thatAlbC is active in vitro. The purified enzyme
can use aminoacylated tRNAPhe purified from E. coli as the
substrates to produce cFF (2,5,7). Based on these findings,
we performed all experiments described herein using the se-
quences of E. coli tRNAs, in particular that of the unique
tRNAPhe isoacceptor. To determine the importance of post-
transcriptional modifications of tRNAPhe on AlbC activity,
we compared its cFF-synthesizing activity using tRNAPhe
either purified from E. coli or obtained by in vitro transcrip-
tion.We used a coupled PheRS-AlbC assay to generate Phe-
tRNAPhe in situ andmeasure the time course for the synthe-
sis of cFF at various concentrations of Phe-tRNAPhe (Sup-
plementary Figure S2) (7). The rates of formation of cFF
were deduced from individual kinetics and plotted against
Phe-tRNAPhe concentrations (Figure 1A). The rate of for-
mation of cFF was similar, regardless of the Phe-tRNAPhe
used. This result shows that post-transcriptional modifica-
tion of the tRNAPhe is not essential for enzymatic activity.
The tRNAs used in subsequent experiments were obtained
by in vitro transcription, except where otherwise stated.
AlbC does not use all Leu-tRNALeu isoacceptors. We
tested the cyclodipeptide-synthesizing activity of AlbC us-
ing both Phe-tRNAPhe and Leu-tRNALeu as substrates.
While the tRNAPhe sequence is unique, E. coli possesses
six different tRNALeu isoacceptors, two of which differ
from each other only by one base in the variable loop
(tRNALeuCAG/tRNALeuCAG*) (Supplementary Figure S3).
We determined the kinetics of cFL, cFF and cLL synthe-
sis by the coupled aaRS-AlbC assay for a fixed concentra-
tion of Phe-tRNAPhe (0.2 M) and various concentrations
of each of the six tRNALeu isoacceptors. Formation of cLL
was not detected in our experimental conditions, regard-
less of the sequence and concentration of tRNALeu isoac-
ceptor. The rates of formation of the cyclodipeptides cFL
and cFF were deduced from individual kinetics and plot-
ted against Leu-tRNALeu concentrations for each isoac-
ceptor (Figure 1B). Leu-tRNALeu isoacceptors were not
used with the same catalytic efficiency by AlbC. The rates
of cFL formation (Figure 1B, left panel) were the high-
est for Leu-tRNALeuCAG or Leu-tRNALeuCAG*, two times
lower for Leu-tRNALeuCAA or Leu-tRNALeuTAG, and close
to zero for Leu-tRNALeuGAG or Leu-tRNALeuTAA. AlbC
synthesized higher quantities of cFF than cFL for equiva-
lent concentrations of Phe-tRNAPhe and Leu-tRNALeu (i.e.
0.2 M), regardless of the Leu-tRNALeu isoacceptor used
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Figure 1. (A) cFF-synthesizing activity of AlbC using either tRNAPhe purified from E. coli (blue) or tRNAPhe obtained by in vitro transcription (orange).
Enzymaticmeasurementswere performed as described in ‘Materials andMethods’ with 50 nMAlbC. The points reported are the result of three independent
experiments. Error bars show the uncertainty onmeasurement. (B) Rate of formation of cFL (left panel) or cFF (right panel) byAlbC for different tRNALeu
isoacceptors. Kinetics of synthesis were determinedwith 0.2MPhe-tRNAPhe and three concentrations of Leu-tRNALeu. Isoacceptors are identified by the
following colours: tRNALeuCAA (light blue), tRNALeuTAG (dark blue), tRNALeuGAG (yellow), tRNALeuTAA (orange), tRNALeuCAG* (grey), tRNALeuCAG
(black). Curves are drawn for clarity and are not representative of kinetic models. (C) Covalent labelling of AlbC, S37A and pSHaeC06 (pSH) by [14C]Phe
transferred from [14C]Phe-tRNAPhe or [14C]Leu transferred from [14C]Leu-tRNALeuCAG. Enzymes were incubated with labelled aa-tRNA, as described
in ‘Materials and Methods’, separated on SDS-PAGE, then transferred onto a PVDF membrane that was analysed with a radioimager.
(Figure 1B). Thus, AlbC usedmore efficiently Phe-tRNAPhe
than any of the Leu-tRNALeu. The efficiency of cFF syn-
thesis was not affected by the presence of Leu-tRNALeuGAG
or Leu-tRNALeuTAA indicating that these molecules do not
compete with Phe-tRNAPhe for binding to AlbC (Figure
1B, right panel). In contrast, the other four Leu-tRNALeu
isoacceptors inhibited cFF synthesis revealing a competi-
tion with Phe-tRNAPhe.
Phe-tRNAPhe is the first substrate accommodated by AlbC.
The CDPSs AlbC, Rv2275, YvmC-Blic and Nvec-CDPS2
have a common first catalytic step. This step involves the
binding of the first aa-tRNA substrate to the enzyme and
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the subsequent transfer of its aminoacyl moiety onto the
conserved serine residue of the catalytic pocket to form an
acyl-enzyme intermediate (4–7). In all four cases, the for-
mation of the acyl-enzyme was tested using a unique aa-
tRNA as a substrate since these enzymes synthesize homo-
cyclodipeptides (cYY for Rv2275 and cLL for YvmC-Blic;
cFF for AlbC and Nvec-CDPS2). We used the property of
AlbC to synthesize the heterocyclodipeptide cFL to inves-
tigate substrate-binding order. AlbC was incubated with ei-
ther [14C]Phe-tRNAPhe or [14C]Leu-tRNALeuCAG and the
formation of an acyl-enzyme intermediate was determined
by autoradiography following sodium dodecyl sulphate-
polyacrylamide gel electrophoresis (SDS-PAGE) and trans-
fer onto a PVDF membrane (5). Formation of [14C]AlbC
was detected with [14C]Phe-tRNAPhe but not with [14C]Leu-
tRNALeuCAG (Figure 1C), indicating that Phe-tRNAPhe
is the first substrate of AlbC. As a negative control, we
showed that an inactive AlbC variant carrying a S37A
substitution (5) was not labelled upon incubation with
[14C]Phe-tRNAPhe in the same conditions. As a positive
control for the formation of an acyl-enzyme with [14C]Leu-
tRNALeuCAG, we used CDPS pSHaeC06 from Staphylococ-
cus haemolyticus, whichmainly synthesizes cLL (2). Finally,
the LS-MS/MS coupled assay with unlabelled substrates
was used to check that the AlbC and pSHaeC06 enzyme
preparations used for these experiments were fully func-
tional.
Specificity determinants in aa-tRNAs substrates of AlbC
The pair G1-C72 of the second substrate is essential for
cFL synthesis. Comparison of the sequences of the six
tRNALeu isoacceptors of E. coli revealed that a wobble
base pair G1•U72 is present in the distal position of the
acceptor arm of the two tRNALeu isoacceptors that are
not used as substrates by AlbC, i.e. Leu-tRNALeuGAG and
Leu-tRNALeuTAA. In contrast, the four other Leu-tRNALeu
isoacceptors and Phe-tRNAPhe possess a canonical G1-
C72 base pair at this position (Figures 1B and 2A). We
introduced a U to C base substitution at position 72 of
tRNALeuTAA to restore a G1-C72 Watson–Crick base pair
in the acceptor arm of this tRNA. A second tRNALeuTAA
mutant was constructed by introducing an A1-U72 base
pair at the same position. tRNALeuTAA was preferred to
tRNALeuGAG for this analysis since the acceptor stems
tRNALeuTAA and tRNAPhe only differ by U and C at po-
sition 72 (Figure 2A). This allowed comparison of Phe-
tRNAPhe with a Leu-tRNALeuTAA variant containing iden-
tical acceptor stems. The mutants were used as substrates
in the coupled aaRS-AlbC assay. This assay was carried
out as described above for the screening of Leu-tRNALeu
isoacceptors, except that the KCl concentration was 50 mM
instead of 150 mM, to maximize enzymatic activity. Leu-
tRNALeuTAA and Leu-tRNALeuCAG were analysed in the
same experimental conditions for comparison. The results
are presented in Figure 2B. The U72C mutation in Leu-
tRNALeuTAA resulted in an enzymatic activity close to that
measured for the best isoacceptor, Leu-tRNALeuCAG. The
G1A mutation in Leu-tRNALeuTAA did not enable the sig-
nificant formation of cFL, as observed for its wild-type
counterpart, Leu-tRNALeuTAA. Our results clearly show
that the pair G1-C72 is a key identity determinant for the
second substrate of AlbC.
In addition, we investigated the capacity of G1-C72
tRNALeuTAA, which has an acceptor stem identical to that
of tRNAPhe, to bind AlbC as a first substrate. We did not
detect any signal using [14C]Leu G1-C72 tRNALeuTAA as a
substrate in the acyl-enzyme formation assay (Supplemen-
tary Figure S4). Formation of cLL was also not detected
using G1-C72 tRNALeuTAA as the sole substrate. Thus, the
sequence of the tRNAPhe acceptor stem is not the key iden-
tity determinant for the first substrate of the reaction.
Recognition of the sequence G1-C72 versus C1-G72 for the
two substrates of AlbC. The last base pair of the accep-
tor stem of tRNATyr is a key element for the recogni-
tion of this tRNA by TyrRSs. This base pair is responsi-
ble for the absence of cross reactivity between archeal or
eukaryotic TyrRS-tRNATyr and bacterial TyrRS-tRNATyr
(recognition of C1-G72 and G1-C72, respectively) (14,15).
To investigate whether AlbC can also discriminate G1-C72
from C1-G72, we constructed the C1-G72 tRNAPhe and
C1-G72 tRNALeuCAG mutants (tRNALeuCAG being the best
tRNALeu isoacceptor substrate). These two mutants could
not be obtained by in vitro transcription. They were con-
structed by mutagenesis from natural tRNAs and produced
by overexpression in E. coli. The cFF-synthesizing activ-
ity of AlbC was more than 10-fold lower with the C1-G72
tRNAPhe mutant than for the wild-type tRNAPhe (Figure
3A) whereas similar amounts of phenylalanyl-enzyme were
formed (Figure 3B). These results show that AlbC does not
discriminate G1-C72 from C1-G72 for the first substrate but
does for the second one. This conclusionwas also supported
by comparison C1-G72 and wild-type tRNALeuCAG as the
second substrate. The formation of cFL was strongly de-
creased by the C1-G72 mutation and inhibition of cFF was
also reduced (Figure 3C). As a wild-type tRNALeuCAG ref-
erence, we used tRNALeuCAG produced by overexpression
in E. coli. The rates of cFL or cFF synthesis were similar to
those observed with tRNALeuCAG obtained by in vitro tran-
scription (Figure 3C), indicating that post-transcriptional
modification of the second aa-tRNA substrate is not essen-
tial for enzymatic activity.
Regions of AlbC involved in interaction with tRNAs
Interaction of aa-tRNAs with the basic patch of AlbC. We
previously substituted each of the basic residues located in
helix 4 with alanine. When expressed in E. coli, most of
the resulting variants produced lower amounts of cFL than
the wild-type enzyme, suggesting that these basic residues
interact with the tRNA moiety of the substrates (5). We se-
lected and purified AlbC variants encompassing residues
distributed across the whole basic patch, namely R80A,
R91A, K94A, R98A, R102A and R98A/R99A (Figure 5).
We first investigated the propensity of the variants to form
the acyl-enzyme intermediate with either Phe-tRNAPhe or
Leu-tRNALeuCAG. Similar to the wild-type enzyme, la-
belled intermediates were only detected in the presence of
[14C]Phe-tRNAPhe, indicating that Phe-tRNAPhe was also
the first substrate accommodated by each of the variants
(Figure 4A and Supplementary Figure S5). The amount of
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Figure 2. (A) Sequences of the acceptor arm of the natural and mutant tRNAs used in this study. (B) Rate of formation of cFL (left panel) and cFF (right
panel) by AlbC using tRNALeuTAA mutants: G1-C72 tRNALeuTAA (grey) or A1-U72 tRNALeuTAA (light blue). Wild-type tRNALeuTAA (orange) was used
as a control and tRNALeuCAG (black) as a reference of substrate recognized by AlbC. Kinetics of synthesis were determined as for experiments shown in
Figure 1, except for KCl concentration (see results). Curves are drawn for clarity and are not representative of kinetic models.
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Figure 3. (A) cFF-synthesizing activity of AlbC using either Phe-tRNAPhe purified from E. coli (black/grey) or Phe C1-G72 tRNAPhe (orange/yellow).
The points reported are the result of two independent experiments. Error bars show the uncertainty on measurement. Curves are drawn for clarity and are
not representative of kinetic models. Enzymatic measurements were performed as described in ‘Materials and Methods’ with 50 nM AlbC. (B) Covalent
labelling ofAlbC and S37Aby [14C]Phe-tRNAPhe or [14C]PheC1-G72 tRNAPhe. Enzymeswere incubatedwith labelled aa-tRNA, as described in ‘Materials
and Methods’, separated on SDS–PAGE, then transferred onto a PVDF membrane that was analysed with a radioimager. (C) Rate of formation of cFL
(left panel) and cFF (right panel) by AlbC using tRNALeuCAG obtained by in vitro transcription (black), tRNALeuCAG purified from E. coli (grey) or
Leu C1-G72 tRNALeuCAG (orange). Kinetics of synthesis were determined as described in Figure 1. Curves are drawn for clarity and are not representative
of kinetic models.
phenylalanyl-enzyme detected was decreased for all vari-
ants. In particular, substitutions of residues R98 and R99
located in the C-terminal part of helix 4 prevented acyla-
tion. These results show that the basic patch of helix 4 of
AlbC is involved in the binding of the first substrate Phe-
tRNAPhe.
We wondered if information regarding the binding of
the second substrate could be obtained from measuring the
activity of these different variants. We used Phe-tRNAPhe
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Figure 4. Covalent labelling of AlbC and variants by [14C]Phe transferred
from [14C]Phe-tRNA Phe. AlbC was used as positive control for the for-
mation of phenylalanyl-enzyme and S37A was used as a negative control
in this experiment (not shown). Enzymes were incubated with labelled aa-
tRNA, as described in ‘Materials andMethods’, separated on SDS–PAGE,
then transferred onto a PVDF membrane that was analysed with a ra-
dioimager. Detection of potential leucyl-enzyme intermediates is shown in
Supplementary Figure S5. (A) Variants of the basic patch. (B) Variants of
the loops 6–7 and 6–8. Proteins were analysed on different gels. AlbC
was loaded onto each gel as a standard.
and three different Leu-tRNALeu isoacceptors representa-
tive of the different activity patterns observed for wild-
type AlbC (Leu-tRNALeuCAG, Leu-tRNALeuCAA and Leu-
tRNALeuTAA, see Figure 1B). In standard assay conditions
(50 nM AlbC or AlbC variant, 0.25 M Phe-tRNAPhe and
0.22 M Leu-tRNALeu isoacceptor), the amounts of cy-
clodipeptides produced by the variants were under the de-
tection threshold (25–30 nM). We modified the experimen-
tal conditions so that enzyme/substrate ratios were set at
values similar to those used in the acyl-enzyme detection
assay (i.e. 1.5 M AlbC or AlbC variant, 0.75 M Phe-
tRNAPhe and 0.66 M Leu-tRNALeu isoacceptor). All of
the variants showed lower cyclodipeptide-synthesizing ac-
tivity than the wild-type enzyme; the more affected being
the variant R98A/R99A (Table 1A). For each variant, the
cFL- and cFF-synthesizing activities were decreased by the
same factor, regardless of the tRNALeu isoacceptor used.
As none of the substitutions changed the pattern of use of
the second substrate, it is likely that the basic residues of the
helix 4 are not involved in its binding.
Implication of other AlbC residues in tRNA interaction.
Bonnefond et al. showed that deletion of the R158-V166
region that corresponds to the loop 6–7 abolished non-
acylated tRNALeu binding to CDPS YvmC (PDB, 3OQH)
(6). To evaluate the role of this region of AlbC in tRNA
binding, we substituted polar residues N159, R160, D163
and D205 with alanine (D205 belongs to the loop 6–8
but is close to N159; Figure 5). Incubation of the vari-
ants with [14C]Phe-tRNAPhe indicated that substitutions
N159A, R160A and D163A did not affect phenylalanyl-
enzyme formation (Figure 4B). No labelled enzyme was
detected with [14C]Leu-tRNALeu (Supplementary Figure
S5). These results show that this region of AlbC is not in-
volved in the binding of the first substrate. For the variant
D205A, more labelled phenylalanyl-enzyme was detected
Figure 5. AlbC regions involved in interaction with tRNA substrates. The
overall structure of AlbC (PDB, 3OQV) is shown in surface mode. The
patch of basic residues located on helix 4 is coloured in blue; the residues
substituted in this study are in dark blue. The loop 6–7 is coloured in
green; the residues substituted in this study are in dark green. The residue
D205 belonging to the loop 6- 8 is coloured in dark red.
(Figure 4B). This was the only variant for which a signif-
icant amount of leucyl-enzyme intermediate was also de-
tected (Supplementary Figure S5).
We next determined the activity of these variants in the
presence of the different Leu-tRNALeu isoacceptors (Ta-
ble 1A). The N159A and R160A substitutions decreased
cyclodipeptide production. Synthesis of cFL was more af-
fected than that of cFF. Furthermore, the decrease in activ-
ity of the variant N159A varied according to the tRNALeu
isoacceptor used. These results suggest an involvement of
both residues in the binding of the second substrate. For
the variants D163A and D205A, as for the wild-type en-
zyme, the phenylalanine present in the enzymatic assay was
completely incorporated into cFF and cFL, preventing a
comparison of their activities. A newmeasurement was per-
formed with reduced concentrations of enzyme and sub-
strates (i.e. 300 nM enzyme, 0.25 M Phe-tRNAPhe and
0.22 nM Leu-tRNALeuCAG) (Table 1B). Both variants syn-
thesized much more cFF and cFL than the wild-type en-
zyme. In addition, the pattern of use of the different isoac-
ceptors tRNALeu changed. Both variants used preferen-
tially tRNALeuCAA, followed by tRNALeuCAG, and then
by tRNALeuTAA. These results show that modification of
residues D163 and D205 changed tRNALeu isoacceptor
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Table 1. cFF and cFL synthesis activity of AlbC variants with different tRNALeu isoacceptors
Activities are expressed in concentration of cyclodipeptides (nM) after 21 min of reaction; D, detectable. (A) The standard enzymatic assay was performed
with 0.75MPhe-tRNAPhe, 0.66MLeu-tRNALeu isoacceptor and 1.5MAlbC or AlbC variant (50 mMKCl). Under these conditions, wild-type AlbC
catalysed the complete incorporation of Phe into cFL and cFF. An additional assay was performed in non-limiting conditions using 150 nM AlbC (1/10).
(B) The most active variants were tested with diluted concentrations of enzyme and both tRNA substrates. The enzymatic assay was performed with 0.25
M Phe-tRNAPhe, 0.22 M Leu-tRNALeu isoacceptor and 300 nM AlbC or AlbC variant (50 mM KCl). Residual activity (% of wild-type activity) is in
grey.
specificity, indicating their involvement in the binding of the
second substrate.
DISCUSSION
Here, we show that AlbC discriminates between its two sub-
strates and possesses a different binding site for each of
them.
AlbC first specifically interacts with Phe-tRNAPhe, form-
ing a phenylalanyl-enzyme intermediate. Phenylalanine is
also the amino acid preferentially incorporated into cy-
clodipeptides synthesized by AlbC. This confirms the previ-
ous assumption that the preferred amino acid is first bound
to the CDPS and remains in the catalytic pocket as an
acyl-enzyme intermediate (3,5,6). We did not detect a co-
valent leucyl-enzyme intermediate when leucylated G1-C72
tRNALeuTAA was used as a substrate. The acceptor arm
sequence of G1-C72 tRNALeuTAA is identical to that of
tRNAPhe. This indicates that the nature of the amino acid
loaded onto tRNA is a key determinant of the specificity of
AlbC for its first substrate.
We analysed the interaction of AlbC with Leu-tRNALeu
as a second substrate by measuring its enzymatic activ-
ity with each of the six different tRNALeu isoacceptors.
AlbC does not use all of the Leu-tRNALeu isoacceptors
as a second substrate, implying the involvement of the
tRNA moiety in the recognition of the second substrate.
The two tRNAsLeu not used as substrates (tRNALeuTAA and
tRNALeuTAG) are the only ones to have a U base at posi-
tion 72. Mutation of this position (U72C) in tRNALeuTAA
was sufficient for high AlbC activity. This mutation re-
stores a Watson–Crick base pair G1-C72. However, de-
spite the presence of Watson–Crick base pairing, the A1-
U72 tRNALeuTAA mutant is not a substrate of AlbC,
and the C1-G72 tRNALeuCAG mutant is a poor substrate
of AlbC. The base pair G1-C72 of the acceptor arm is
hence a key determinant for the interaction of AlbC
with its second aa-tRNA substrate. The preference of
AlbC for tRNALeuCAG/tRNALeuCAG* versus tRNALeuCAA/
tRNALeuTAG may also be related to particular sequences
in the acceptor arm. The best Leu-tRNALeu substrates
(tRNALeuCAG/tRNALeuCAG*) are the only substrates pos-
sessing the base pairs A4-U69 and A5•C68. The less effi-
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cient Leu-tRNALeu substrates (tRNALeuCAA/ tRNALeuTAG)
share the sequences G4-C69 and A6-U67. Systematic muta-
tional analysis will be required to clarify the involvement
of these base pairs in the efficiency of substrate usage. The
aminoacyl moiety of the second aa-tRNA also appears to
be important for its interaction with the CDPS. Indeed,
AlbC prefers Phe-tRNAPhe to Leu-G1-C72 tRNALeuTAA as
a second substrate, despite the fact that these two substrates
have the same acceptor arm sequence. In addition, more
cFF was synthesized than cFL for equivalent concentra-
tions of Phe-tRNAPhe and Leu-tRNALeu. In vivo,AlbC pro-
duces more cFL than cFF (2). Dong and collaborators de-
termined the abundances of tRNA in E. coli at different
growth rates (16). Whatever the growth rate, there is about
9-fold more tRNALeu than tRNAPhe in E. coli cells (about
7-fold more if we only consider tRNALeu isoacceptors that
are efficiently used by AlbC). For a tRNALeu/tRNAPhe ra-
tio representative of in vivo conditions, we indeed observed
in vitro higher amounts of cFL than cFF.
In E. coli, all amino acids except Asn, Gln, Ile, Pro and
Trp can be loaded onto tRNAs that contain aG1-C72 pair in
the acceptor arm (http://gtrnadb.ucsc.edu/Esch coli K12/
Esch coli K12-align.html). However, only a few of them
can be incorporated into cyclodipeptides by AlbC as a sec-
ond substrate, as shown by the cyclodipeptide production
profile of recombinant E. coli producing AlbC (2). This
clearly indicates that other determinants are important for
the selection of the second substrate by AlbC. Phe, Leu,
Tyr, Met and Ala amino acids are all incorporated into cy-
clodipeptides byAlbC. Closer examination of the sequences
encoding tRNAs that are associated with these amino acids
shows that these sequences all contain the G1-C72 pair as
well as A76C75C74A73 in the single strand extremity. The rest
of the sequence of these tRNAs, including the acceptor arm,
is highly variable. Other E. coli tRNAs that possess the se-
quence A76C75C74A73C72-G1 can be charged with Arg, Lys
or Val, but these amino acids are not incorporated by AlbC
into cyclodipeptides. This definitely indicates that the selec-
tivity of AlbC for its second substrate involves tRNA se-
quences but also the nature of the amino acid.
AlbC originates from S. noursei, therefore, we examined
the tRNA sequences in this host. The sequences are not
available for S. noursei but can be found for many other
Streptomyces species. All the Streptomyces tRNA sequences
contain A76C75C74A73C72-G1, suggesting that all tRNAPhe
and tRNALeu are substrates for AlbC. The acceptor arm
of one Streptomyces tRNALeu isoacceptor, tRNALeuTAA, is
identical to that of E. coli tRNAPhe. The sequence of this
tRNALeuTAA is highly conserved in Streptomyces species
and this tRNA recognizes a rare codon. tRNALeuTAA has
been thoroughly studied: it is not required for growth but
is required for some aspects of secondary metabolism and
morphological development (17). This tRNAwould be par-
ticularly involved in regulatory pathways of biosynthesis of
several antibiotics. Its potential relationship with AlbC re-
mains to be determined.
In view of these results with AlbC, one may wonder if
other CDPSs share the same key determinants for the first
and the second aa-tRNA substrate. Like AlbC, most of the
biochemically characterized CDPSs are promiscuous and
synthesize several cyclodipeptides. One exception to this
rule is the CDPS Amir 4627 from Actinosynnema mirum,
which synthesizes exclusively cWWwhen this enzyme is ex-
pressed in E. coli (18). The sequence of the E. coli tRNATrp
contains the combination of an A1-U72 base pair and a G73
residue, which is a unique feature of tRNATrp in E. coli.
This could contribute to the selectivity of Amir 4627 for
its second amino acid substrate. The tRNA sequence of the
second substrate may also be critical for the determination
of the activity of eukaryotic CDPSs in E. coli. The CDPS
Nvec-CDPS2 from the eukaryotic organism Nematostella
vectensis mainly synthesizes cWX cyclodipeptides when it
is expressed in E. coli (7). The base at position 73 of the
tRNATrp acceptor arm is largely responsible for the very
low cross reactivity between archeal or eukaryotic and bac-
terial TrpRS-tRNATrp pairs: this base is generally adenine
in archeal or eukaryotic tRNATrp and guanine in bacte-
rial tRNATrp (19). Expression of this CDPS in E. coli re-
sults in the synthesis of very small amounts of cWM, cWF
and cWL. A search for tRNATrp sequences in the genome
available for N. vectensis (http://www.ncbi.nlm.nih.gov) re-
vealed five different sequences possessing characteristics of
eukaryotic tRNATrp. However, the acceptor arm sequences
of these five candidates are more similar to E. coli tRNAPhe
or tRNAMet than to E. coli tRNATrp (Supplementary Fig-
ure S6). Thus, an experimental system that uses eukary-
otic tRNAs would probably give a more accurate view of
N. vectensis CDPS activity. It follows that care must be
taken when interpreting the results of activities of CDPSs
expressed in E. coli: discrepancies between E. coli tRNA se-
quences and tRNA sequences in the species from which the
CDPSs originates can give a misleading view of the activity
of these enzymes in their natural environment.
The second important result of our work concerns the
identification of two different regions of AlbC that inter-
act with either the tRNA moiety of the first or that of the
second substrate. We show that the basic patch of helix 4
is important for the binding of the first substrate. All the
substitutions involving amino acids in this patch dramat-
ically affected enzymatic activity in vitro, probably by per-
turbing the binding of the tRNAmoiety. This indicates that
all these residues, in particular R98 and R99, participate in
the interaction. The basic patch does not belong to a clearly
defined class of RNA-binding motif. It nevertheless shares
features with some of them (20). In particular, the drastic
decrease of enzymatic activity that is associated with sub-
stitutions of any residues of the motif has also been de-
scribed for double-stranded RNA-binding motifs (20,21).
Arginines are essential residues for RNA binding. They are
involved in non-specific interactions mediated by their posi-
tive charge. However, they also participate in specific hydro-
gen bonding networks with RNA bases, especially guanines
(20,22,23). The occurrence of arginine•guanine pairs in
specific RNA–protein interactions is very high in complex
structures (24). The sequences of all the acceptor stems of
aa-tRNAs used as substrates by AlbC have a high GC con-
tent, which is consistent with RNA–protein interactions in-
volving arginines. Nonetheless, many new putative CDPSs
that have been identified by Basic Local Alignment Search
Tool searches (3) are devoid of the basic patch that is found
in AlbC and other characterized CDPSs (2,5). These puta-
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tive CDPSs possess a large number of aspartic and glutamic
acids, asparagine, glutamine, serine and threonine at a sim-
ilar position to the basic patch of AlbC. These residues are
known to interact specifically with nucleotide bases other
than guanine. Thus, residues of helix 4 of these putative
CDPSs may in part determine substrate specificity by inter-
acting only with a limited number of tRNA sequences.
We found that the binding of the second substrate was af-
fected when residues belonging to the loop 6–7 or loop
6–8 were substituted for alanine. In particular, binding
was strongly affected inD163A (in loop 6–7) andD205A
(in loop 6–8). In both TrpRSs and TyrRSs, the loop
equivalent to this loop 6–7 is involved in tRNA bind-
ing (25–28). Furthermore, during the binding of the second
substrate, AlbC discriminates between G1-C72 and C1-G72,
similar to TyrRSs and TrpRSs (14,15,19). This discrimina-
tion can be only achieved if the interaction of the enzyme
with its substrate occurs from the major groove side of the
acceptor stem (22,23), which is also a distinctive feature
of class-Ic aaRSs (27,28), apparently shared by AlbC. This
suggests that CDPSs may have retained some characteris-
tics of class-Ic aaRSs regarding their interaction with their
second substrate. In TyrRSs, a second cluster of amino acids
belonging to the Rossmann-fold is involved in N1 recogni-
tion (27–30). In AlbC, this region corresponds to residues
of helix 8 (P207-L212) and part of the following loop. Al-
though AlbC has none of the consensus sequences that al-
low TyrRSs to specifically recognize G1-C72 or G1-C72 (31),
mutational analysis of this region should be carried out to
test its possible involvement in tRNA binding.
Both residues D205, which neighbours helix 8, and
D163 from the loop 6–7 appear to have a negative effect
on catalytic activity, because substitution of these residues
with alanine creates variants with higher catalytic activity.
Such a phenomenon is not uncommon in enzymatic world
(32). Both residues may be incorporated to improve enzyme
specificity at the expense of efficiency, perhaps by prevent-
ing the binding of undesired tRNA sequences. Bedouelle
et al. (33) identified such a residue in TyrRS from Bacil-
lus stearothermophilus: the primary function of an acidic
residue, E152, was to inhibit the use of non-cognate tR-
NAs by electrostatic and steric repulsions, and hence en-
sure enzyme specificity for tRNATyr. Another possibility is
that D205 andD163 residuesmay reduce the affinity of cog-
nate aa-tRNAs to AlbC so that the major fractions of Phe-
tRNAPhe and Leu-tRNALeu are used for ribosomal protein
synthesis.
In conclusion, we demonstrate that AlbC handles differ-
ently its two substrates. The binding of its first substrate is
highly dependent on the aminoacyl moiety of the tRNA,
whereas both the aminoacylmoiety and the tRNA sequence
itself are essential for the specific recognition of the second
substrate. This first and second substrates bind to the en-
zyme at different sites: binding of the first substrate involves
the basic patch centred on helix 4 whereas binding of the
second substrate involves the loop 6–7. These regions
modulate the specificity of AlbC though specific interac-
tions with appropriate tRNA sequences. Noted that the two
binding sites could be simultaneously present on the enzyme
or the second binding-site could result from a structural re-
organisation induced by the formation of the aminoacyl-
enzyme intermediate. The interaction of AlbC with its sec-
ond aa-tRNA substrate shares features with the interaction
of class-Ic aaRSs with their aa-tRNA substrates. Comple-
mentary biophysical analyses will be required to precisely
define the outlines of these two binding sites and determine
how many features CDPSs have retained from their aaRS
ancestors.
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